UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Patient reported late effects of gynecological cancer treatment

Gynecologic oncology, 2012-03, Vol.124 (3), p.399-403

2012

Volltextzugriff (PDF)

Angiogenesis in Collagen I Requires α2β1 Ligation of a GFPGER Sequence and Possibly p38 MAPK Activation and Focal Adhesion Disassembly

The Journal of biological chemistry, 2003-08, Vol.278 (33), p.30516-30524

2003

Volltextzugriff (PDF)

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-04, Vol.106, p.1-7

2017

Volltextzugriff (PDF)

Patient-reported outcomes after prostate cancer treatment

Journal of clinical urology, 2014-07, Vol.7 (4), p.286-294

2014

Volltextzugriff (PDF)

Patient-reported outcomes from adolescent/young adult (AYA) cancer survivors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9605-9605

2014

Volltextzugriff (PDF)

P3.02c-069 Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Outcomes with Nivolumab in Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1318

2017

Volltextzugriff (PDF)

P3.02c-028 Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC): Topic: IT

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1289-S1289

2017

Volltextzugriff (PDF)

P3.02c-029 Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1290

2017

Volltextzugriff (PDF)

P3.02c-029 Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab: Topic: IT

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1290-S1290

2017

Volltextzugriff (PDF)

P3.02c-069 Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Outcomes with Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Topic: IT Biomarkers

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1318-S1318

2017

Volltextzugriff (PDF)

P3.02c-028 Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1289

2017

Volltextzugriff (PDF)

Patient-reported toxicity after treatment for prostate cancer (PC)

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.221-221

2012

Volltextzugriff (PDF)

Risk for unplanned hospital readmission of patients with cancer: results of a retrospective medical record review

Oncology nursing forum, 2006-05, Vol.33 (3), p.E44

2006

Volltextzugriff (PDF)

Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer

Journal of oncology practice, 2016-05, Vol.12 (5), p.e527

2016

Volltextzugriff (PDF)

Angiogenesis in Collagen I Requires Î±2Î²1 Ligation of a GFPGER Sequence and Possibly p38 MAPK Activation and Focal Adhesion Disassembly

The Journal of biological chemistry, 2003-08, Vol.278 (33), p.30516

2003

Volltextzugriff (PDF)

Angiogenesis in collagen I requires alpha2beta1 ligation of a GFPGER sequence and possibly p38 MAPK activation and focal adhesion disassembly

The Journal of biological chemistry, 2003-08, Vol.278 (33), p.30516-30524

2003

Volltextzugriff (PDF)

Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome

The New England journal of medicine, 2014-11, Vol.371 (22), p.2061-2071

2014

Volltextzugriff (PDF)

Partial and Transitional Atrioventricular Septal Defect Outcomes

The Annals of thoracic surgery, 2010-02, Vol.89 (2), p.530-536

2010

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(8)
Female
(7)
Life Sciences & Biomedicine
(7)
Science & Technology
(7)
Adult
(6)
Male
(6)
Aged
(4)
Aged, 80 And Over
(4)
Middle Aged
(4)
Treatment Outcome
(4)
Young Adult
(4)
Child
(3)
Child, Preschool
(3)
Infant
(3)
Oncology
(3)
Retrospective Studies
(3)
Adolescent
(2)
Angiotensin Ii Type 1 Receptor Blockers - Therapeutic Use
(2)
Atenolol - Therapeutic Use
(2)
Biological And Medical Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient reported late effects of gynecological cancer treatment

Angiogenesis in Collagen I Requires α2β1 Ligation of a GFPGER Sequence and Possibly p38 MAPK Activation and Focal Adhesion Disassembly

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Patient-reported outcomes after prostate cancer treatment

Patient-reported outcomes from adolescent/young adult (AYA) cancer survivors

P3.02c-069 Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Outcomes with Nivolumab in Non-Small Cell Lung Cancer (NSCLC)

P3.02c-028 Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC): Topic: IT

P3.02c-029 Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab

P3.02c-029 Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab: Topic: IT

P3.02c-069 Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Outcomes with Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Topic: IT Biomarkers

P3.02c-028 Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)

Patient-reported toxicity after treatment for prostate cancer (PC)

Risk for unplanned hospital readmission of patients with cancer: results of a retrospective medical record review

Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer

Angiogenesis in Collagen I Requires Î±2Î²1 Ligation of a GFPGER Sequence and Possibly p38 MAPK Activation and Focal Adhesion Disassembly

Angiogenesis in collagen I requires alpha2beta1 ligation of a GFPGER sequence and possibly p38 MAPK activation and focal adhesion disassembly

Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome

Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy

Partial and Transitional Atrioventricular Septal Defect Outcomes

Suchergebnisse filtern